[HTML][HTML] Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials
C Xue, C Zhou, B Dai, S Yu, C Xu, Z Mao, C Ye… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Background: Blood pressure (BP) control is one of the most important treatments of
Autosomal dominant polycystic kidney disease (ADPKD). The comparative efficacy of …
Autosomal dominant polycystic kidney disease (ADPKD). The comparative efficacy of …
Treatment of subdural and intracerebral haematomas in a haemodialysis patient with tranexamic acid
B Vujkovac, M Šabovič - Nephrology Dialysis Transplantation, 2000 - academic.oup.com
Discussion Haemodialysis patients and patients with other types of bleeding tendency are
prone to spontaneous and traumatic subdural and intracerebral haematoma. Moreover, the …
prone to spontaneous and traumatic subdural and intracerebral haematoma. Moreover, the …
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease
T Ecder, AB Chapman, GM Brosnahan… - American journal of …, 2000 - Elsevier
Hypertensive patients with autosomal dominant polycystic kidney disease (ADPKD) have a
faster progression to end-stage renal disease (ESRD) than their normotensive counterparts …
faster progression to end-stage renal disease (ESRD) than their normotensive counterparts …
Does long‐term administration of sodium thiosulphate inhibit progression to renal failure in nephrocalcinosis?
B Agroyannis, H Tzanatos… - Nephrology Dialysis …, 2001 - academic.oup.com
In a previous communication, about 10 years ago, we presented two patients with
erythrocytosis associated with renal tubular acidosis type‐I (RTA‐I). At that time their work …
erythrocytosis associated with renal tubular acidosis type‐I (RTA‐I). At that time their work …
Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to …
P Ruggenenti, A Perna, C Zoccali… - Journal of the …, 2000 - journals.lww.com
Abstract In the Ramipril Efficacy in Nephropathy study, ramipril decreased the rate of GFR
decline (ΔGFR) and progression to end-stage renal disease (ESRD) in 352 patients with …
decline (ΔGFR) and progression to end-stage renal disease (ESRD) in 352 patients with …
Stone prevalence in autosomal dominant polycystic kidney disease: a systematic review and meta-analysis
V Kalatharan, G Grewal, DM Nash… - … Journal of Kidney …, 2020 - journals.sagepub.com
Background: It is uncertain how often patients with autosomal dominant polycystic kidney
disease (ADPKD) develop kidney stones. Objective: To review English-language studies …
disease (ADPKD) develop kidney stones. Objective: To review English-language studies …
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
L Sans-Atxer, R Torra… - Clinical kidney …, 2013 - academic.oup.com
Cardiovascular (CV) complications are the major cause of death in autosomal-dominant
polycystic kidney disease (ADPKD) patients. Hypertension is common in these patients even …
polycystic kidney disease (ADPKD) patients. Hypertension is common in these patients even …
Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease
SA Grampsas, PS Chandhoke, J Fan, MA Glass… - American journal of …, 2000 - Elsevier
The prevalence of nephrolithiasis is considerably greater in patients with autosomal
dominant polycystic kidney disease (ADPKD) than in the general population. We evaluated …
dominant polycystic kidney disease (ADPKD) than in the general population. We evaluated …
[HTML][HTML] HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the …
T Bais, E Meijer, BJ Kramers, P Vart, M Vervloet… - Trials, 2024 - Springer
Background Autosomal dominant polycystic kidney disease (ADPKD) leads to progressive
renal cyst formation and loss of kidney function in most patients. Vasopressin 2 receptor …
renal cyst formation and loss of kidney function in most patients. Vasopressin 2 receptor …
[HTML][HTML] Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease
VE Torres, KZ Abebe, RW Schrier, RD Perrone… - Kidney international, 2017 - Elsevier
The CRISP study of polycystic kidney disease (PKD) found that urinary sodium excretion
associated with the rate of total kidney volume increase. Whether sodium restriction slows …
associated with the rate of total kidney volume increase. Whether sodium restriction slows …